WELCOME NEW COUNCIL MEMBER – MARK CHAPMAN, Medtronic

IMSTA’s Chairman and Board of Directors are pleased to welcome Mark Chapman to the IMSTA Council.

Mark has been with Medtronic since 2001, and currently heads the Health Economics team where he is responsible for Medtronic’s strategies as related to Health Economics, economic regulator submissions and associated clinical study design as related to the quantification of cost and effectiveness. Prior to joining Medtronic, he trained as a Clinical Physiologist, and worked for 11 year within the UK NHS, Tertiary Cardiac Care, with a specialist interest in complex cardiac devices.

Mark currently sits as the Med-Tech Industry representative within NICE technology appraisal programme and is a member of the External Advisory Board, University of Leeds EPSRC Centre for innovative Manufacturing of Medical Devices. Previously has also undertaken secondment within the UK Government, Office for Life Science, Department of Business, as Med Tech Policy Advisor. Supporting the work of the UK Life Sciences Strategy.  

Mark holds; a BSc (Hons) in Applied Biological Sciences from Manchester Metropolitan University, Post Graduate Diploma –Health Economics from York University and received his MBA from Keele University, School of Public Policy.